Articles related to MEDICAL SOCIETIES

The National Comprehensive Cancer Network (NCCN) Guidelines are continuously updated to reflect the latest advances in cancer treatment. New agents and combinations are introduced all the time, and NCCN guidelines are refreshed regularly to include new technologies, drugs, and approaches. The guidelines are developed and maintained by panels of experts who review the latest science, including new publications, FDA approvals, and information presented at scientific meetings. The goal is to include new information that has been sufficiently validated to provide clinical utility and benefit to patients. In-person interactions at the NCCN conference are essential to the exchange of ideas and the creation of relationships that lead to shared learning and collaboration. The NCCN plans to continue evolving and adapting to the changing landscape of cancer care by keeping up with the latest data and by focusing on inclusiveness, equity, and access. The organization aims to expand access to traditionally marginalized and underserved populations and to reach out to communities through their trusted sources. The NCCN is committed to learning from patients and communities to ensure that everyone benefits from advances in cancer treatment.

The American Optometric Association (AOA) has released a revised clinical practice guideline to help doctors of optometry provide comprehensive eye and vision exams for adults. The guideline was created due to the significant public and economic impact of increasing visual impairments, blindness, and an aging population in the United States. The guideline recommends annual comprehensive eye exams for adults aged 18-64 to optimize visual function, detect sight-threatening eye and systemic health conditions early, and prevent or reduce vision loss. The guideline emphasizes that early detection of eye and vision problems can improve a patient’s visual function and quality of life.

In total, 1,732 grants were included in the study. The grants were mostly given to researchers in the United States (93%), and the majority of recipients were men (61%). Researchers at four institutions received more than one-third of the grants: Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, MD Anderson Cancer Center, and John Hopkins University.

The update was based on the findings of 31 systematic reviews and 16 randomized controlled trials (RCTs) chosen from a total of 820 publications. The investigators set out to answer seven questions: